Methylsulfonylmethane / HO-1 Cancer Research Results

MSM, Methylsulfonylmethane: Click to Expand ⟱
Features:
MSM (Methylsulfonylmethane) is a naturally occurring organosulfur compound often used as a dietary supplement for its anti-inflammatory and antioxidant effects. While most well-known for joint health.
-MSM is actually a metabolite of DMSO (dimethyl sulfoxide) 
-Generally Recognized as Safe     Possible Interactions: aspirin, warfarin, NSAIDS

-Supplement dosage: 500mg 2-3times/day


-Anti-inflammatory: ↓NF-κB, ↓COX-2 and iNOS
-↓STAT3
-↓Cyclin D1 and CDK4, halting cell cycle progression.
-↓MMP-2, MMP-9, VEGF limiting invasion.

Methylsulfonylmethane (MSM) — Cancer-Oriented Time-Scale Flagged Pathway Table
Rank Pathway / Axis Cancer / Tumor Context Normal Tissue Context TSF Primary Effect Notes / Interpretation
1 NF-κB inflammatory transcription NF-κB ↓; COX-2/cytokines ↓ (reported) Inflammation tone ↓ R, G Anti-inflammatory signaling One of the most consistent findings in MSM studies is suppression of NF-κB-linked inflammatory signaling.
2 STAT3 signaling STAT3 phosphorylation ↓ (reported) ↔ R, G Pro-survival pathway suppression STAT3 inhibition has been reported in some breast and other tumor models; relevance depends on tumor type.
3 PI3K / AKT pathway AKT signaling ↓ (reported; model-dependent) ↔ R, G Growth modulation Observed in certain cell lines; should be presented as context-dependent rather than universal.
4 ROS / redox modulation ROS ↓ (often); oxidative stress tone ↓ Oxidative injury ↓ P, R, G Redox buffering MSM is generally described as anti-oxidative/anti-inflammatory rather than pro-oxidant; not a ROS-amplifying therapy.
5 Apoptosis induction Caspases ↑; Bax ↑; Bcl-2 ↓ (reported) ↔ G Cell death signaling Apoptotic effects reported in vitro; usually downstream of inflammatory and survival pathway suppression.
6 Cell-cycle regulation Cell-cycle arrest ↑ (reported) ↔ G Cytostasis Observed in some cancer cell systems; mechanism linked to signaling changes.
7 Migration / invasion (MMPs) MMP expression ↓; migration ↓ (reported) ↔ G Anti-invasive phenotype Reduction in metastasis markers reported in certain preclinical models.
8 ER stress modulation Stress signaling modulation (context-dependent) Proteostasis support R, G Stress pathway modulation Less consistent than NF-κB effects; should be kept qualified.
9 Chemo-/radiation interaction (theoretical) May reduce inflammatory toxicity; may blunt ROS-based therapies Normal tissue protection possible G Adjunct positioning Because MSM is anti-oxidative/anti-inflammatory, positioning with strong pro-oxidant therapies should be considered carefully.
10 Translation constraint Human anti-cancer efficacy not established Generally well tolerated in common supplement ranges — Evidence limitation Evidence base is largely preclinical; clinical oncology data are limited.

Time-Scale Flag (TSF): P / R / G

  • P: 0–30 min (early redox/inflammatory signaling shifts)
  • R: 30 min–3 hr (NF-κB / STAT3 pathway modulation)
  • G: >3 hr (cell-cycle, apoptosis, invasion phenotype changes)


For Alzheimer's (AD):
Methylsulfonylmethane (MSM) in neurobiology is primarily framed as an anti-inflammatory and redox-buffering molecule, not a direct amyloid-clearing or tau-targeting drug. Evidence is largely preclinical (cell + animal models). Position it as a neuroinflammation and oxidative stress modulator.
-Anti-inflammatory: ↓TNF-α, IL-1β, IL-6 
-↓ROS, ↑GSH, ↓NO
-may reduce Aβ plaque burden and tau hyperphosphorylation indirectly
-improves memory in rodents

Methylsulfonylmethane (MSM) — Alzheimer’s Disease (AD) Time-Scale Flagged Pathway Table
Rank Pathway / Axis AD / Brain Context TSF Primary Effect Notes / Interpretation
1 Neuroinflammation (NF-κB / cytokine signaling) Microglial activation ↓; IL-1β/TNF-α ↓ (reported) R, G Anti-inflammatory modulation MSM’s most consistent neuro-relevant signal is suppression of NF-κB-driven inflammatory tone, which is implicated in AD progression.
2 Oxidative stress / redox buffering Lipid peroxidation ↓; ROS tone ↓ (reported) R, G Neuroprotection (stress buffering) MSM is generally described as antioxidant/anti-inflammatory rather than pro-oxidant; may help mitigate oxidative injury.
3 Mitochondrial function support Mitochondrial stress ↓ (context-dependent) R, G Bioenergetic stabilization Indirect support through reduced oxidative and inflammatory burden; not a primary mitochondrial activator.
4 ER stress / proteostasis modulation UPR signaling ↓ (reported in stress models) R, G Proteostasis buffering ER stress is relevant in AD pathology; MSM may attenuate stress signaling in some models.
5 Calcium homeostasis modulation Excitotoxic stress ↓ (indirect) P, R Signal stabilization Primarily indirect via inflammatory and oxidative stress reduction.
6 Aβ pathology (direct evidence) Limited direct evidence of amyloid reduction G Indirect modulation If effects occur, they are likely secondary to reduced oxidative stress and inflammation rather than direct amyloid targeting.
7 Tau phosphorylation Limited direct mechanistic evidence G Indirect modulation No strong mechanistic evidence that MSM directly modulates tau kinases; effects likely indirect.
8 Blood–brain barrier (BBB) considerations CNS exposure plausible but not strongly quantified R PK consideration Systemic exposure is good; CNS-specific pharmacokinetics are less clearly defined.
9 Cognitive outcome evidence Limited direct human AD trial data — Translation constraint Evidence base is largely mechanistic/preclinical; clinical AD efficacy not established.

Time-Scale Flag (TSF): P / R / G

  • P: 0–30 min (early redox/inflammatory signaling shifts)
  • R: 30 min–3 hr (microglial signaling + oxidative stress modulation)
  • G: >3 hr (phenotype-level neuroprotection effects)
HO-1, HMOX1: Click to Expand ⟱
Source:
Type:
(Also known as Hsp32 and HMOX1)
HO-1 is the common abbreviation for the protein (heme oxygenase‑1) produced by the HMOX1 gene.
HO-1 is an enzyme that plays a crucial role in various cellular processes, including the breakdown of heme, a toxic molecule. Research has shown that HO-1 is involved in the development and progression of cancer.
-widely regarded as having antioxidant and cytoprotective effects
-The overall activity of HO‑1 helps to reduce the pro‐oxidant load (by degrading free heme, a pro‑oxidant) and to generate molecules (like bilirubin) that can protect cells from oxidative damage

Studies have found that HO-1 is overexpressed in various types of cancer, including lung, breast, colon, and prostate cancer. The overexpression of HO-1 in cancer cells can contribute to their survival and proliferation by:
  Reducing oxidative stress and inflammation
  Promoting angiogenesis (the formation of new blood vessels)
  Inhibiting apoptosis (programmed cell death)
  Enhancing cell migration and invasion
When HO-1 is at a normal level, it mainly exerts an antioxidant effect, and when it is excessively elevated, it causes an accumulation of iron ions.

A proper cellular level of HMOX1 plays an antioxidative function to protect cells from ROS toxicity. However, its overexpression has pro-oxidant effects to induce ferroptosis of cells, which is dependent on intracellular iron accumulation and increased ROS content upon excessive activation of HMOX1.

-Curcumin   Activates the Nrf2 pathway leading to HO‑1 induction; known for its anti‑inflammatory and antioxidant effects.
-Resveratrol  Induces HO‑1 via activation of SIRT1/Nrf2 signaling; exhibits antioxidant and cardioprotective properties.
-Quercetin   Activates Nrf2 and related antioxidant pathways; contributes to anti‑oxidative and anti‑inflammatory responses.
-EGCG     Promotes HO‑1 expression through activation of the Nrf2/ARE pathway; also exhibits anti‑inflammatory and anticancer properties.
-Sulforaphane One of the most potent natural HO‑1 inducers; triggers Nrf2 nuclear translocation and upregulates a battery of phase II detoxifying enzymes.
-Luteolin    Induces HO‑1 via Nrf2 activation; may also exert anti‑inflammatory and neuroprotective effects in various cell models.
-Apigenin   Has been reported to induce HO‑1 expression partly via the MAPK and Nrf2 pathways; also known for anti‑inflammatory and anticancer activities.
Scientific Papers found: Click to Expand⟱
3848- MSM,    Modulatory effect of methylsulfonylmethane against BPA/γ-radiation induced neurodegenerative alterations in rats: Influence of TREM-2/DAP-12/Syk pathway
- in-vitro, AD, NA
*ROS↓, *Inflam↓, *neuroP↑, *ER(estro)↑, *NRF2↑, *HO-1↑, *Trx1↑, *TXNIP↓, *MDA↓, *NOX↓, *GSH↑, *GPx↑, *SOD↑, *Catalase↑, *BDNF↑, *AChE↓, *p‑tau↓, *Aβ↓,

Showing Research Papers: 1 to 1 of 1

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1

Pathway results for Effect on Cancer / Diseased Cells:


Total Targets: 0

Pathway results for Effect on Normal Cells:


Redox & Oxidative Stress ⓘ

Catalase↑, 1,   GPx↑, 1,   GSH↑, 1,   HO-1↑, 1,   MDA↓, 1,   NRF2↑, 1,   ROS↓, 1,   SOD↑, 1,   Trx1↑, 1,  

Migration ⓘ

TXNIP↓, 1,  

Immune & Inflammatory Signaling ⓘ

Inflam↓, 1,  

Cellular Microenvironment ⓘ

NOX↓, 1,  

Synaptic & Neurotransmission ⓘ

AChE↓, 1,   BDNF↑, 1,   p‑tau↓, 1,  

Protein Aggregation ⓘ

Aβ↓, 1,  

Hormonal & Nuclear Receptors ⓘ

ER(estro)↑, 1,  

Functional Outcomes ⓘ

neuroP↑, 1,  
Total Targets: 18

Scientific Paper Hit Count for: HO-1, HMOX1
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells

Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:124  Target#:597  State#:%  Dir#:%
  wNotes=0  sortOrder:rid,rpid

 

Home Page